Screener
Eligibility screening
Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis
1 US site in MO
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.